Song Among the Ruins by Bondy, Philip K.
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 63 (1990), 249-263
Book Reviews
SONG AMONG THE RUINS. By William J. Schull. Cambridge, MA, Harvard University
Press, 1990. 307 pp. $25.00.
American distress at the horrors produced by the atomic bombs released on
Hiroshima and Nagasaki in 1945 generated a laudable desire to salvage something
positive from the damage. Immediately after the war, the American government sent
survey teams to the bombed cities to evaluate the extent and nature ofthedamage. An
accountofthoseearlydays has appeared in The YaleJournal [1,2]. Thereportofthese
studies led to the establishment ofthe Atomic Bomb Casualty Commission (ABCC),
under the supervision ofthe National Research Council and the National Academy of
Sciences, and with the cooperation ofthe Allied occupying forces and of the Japanese
National Institute ofHealth.
Schull, a newly graduated human geneticist from the University of Michigan, was
recruited for the two years beginning in 1949 to direct field studies on the genetic
impact of the bomb. After he had completed his first tour of duty, he returned
repeatedly to Japan to continue these studies over the next 15 years. His extensive
involvement in Japan gave him a sympathetic attitude toward the Japanese people and
their culture. He was not a mere observer; he studied Japanese, including calligraphy,
and collected Japanese prints, especially those of modern artists. His wife taught
English to Japanese students and studied domestic culture such as flower arranging
and the tea ceremony. Both members ofthe family entered actively into the life ofthe
community. His Japanese students and colleagues were convivial friends and drinking
buddies as well as collaborators.
This book records his reminiscences about his Japanese career. While it discusses a
number ofresearch workers and the projects they undertook, it is not much concerned
with the design or results of the investigations. The volume is a warm, compassionate
personal record ofhis experiences.
Immediately after the war, Japan was a damaged, pauper nation. Schull discusses at
some length the successes of the occupation under General MacArthur in helping
Japan to evolve from an absolute militaristic monarchy to a democracy and from an
impoverished country to one which stands among leaders in world commerce and
manufacturing. Although this theme runs through the entire book, it is summarized at
the end, especially with regard to the evolution ofJapanese medical science.
Because the book is highly personal, it does not serve as a history of the ABCC,
except in the limited arena of Dr. Schull's participation. He hardly mentions the
medical work done by the Commission, and his discussion ofimportant personalities in
the ABCC essentially ignores those who made contributions to any program except
genetics. Even in this area, he does not present the scientific findings, though he
summarizes the implications ofthe research in a few pages at the end ofthe book.
If the reader accepts the author's objective-to provide a personal account of his
experiences and those of his friends-the volume is well worth reading. It does,
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however, suffer from a problem implied by its title. Dr. Schull's attempts to make the
book lyrical lead to the sin ofvivid writing, often complicated by inappropriate usages.
For example, it seems unlikely that the lanes mentioned on page 15 were "tortured";
"tortuous" is more likely. Can sleep come in "dollops" (page 22)? Do physicians
actually ridejeeps like "marauding bees" (page 26)? (Are bees actually marauders?)
What is a "millennia" oflifetimes (page 154)? These usages and many more like them
interfered with my enjoyment of what should otherwise have been a totally pleasant
experience.
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GENE TRANSFER AND GENE THERAPY. Edited by Arthur L. Beaudet, Richard Mulli-
gan, and Inder M. Verma. New York, Alan R. Liss, Inc., 1989. 441 pp. $110.00.
This volume contains the proceedings of a symposium sponsored by DuPont and
UCLA, held in 1988. The date ofthe proceedings is, in fact, its most serious problem.
The field of genetics is moving so rapidly that a 1988 symposium is already seriously
out of date. Nevertheless, this book has great value as a summary of research up to
that time. Over 100 participants, many leaders in genetics research, presented papers
included in this symposium. All of them are original papers, but most are part of
ongoing projects from which much data have already been published.
The symposium is divided into four sections: model systems for gene transfer, gene
transfer and expression, human genetic diseases, and human gene therapy. The last
section is the oneofmost interest toclinicians, butit is also the most sparse. Thesection
on gene transfer and expression, the most lengthy, contains reports ofgene transfer in
mouse systems, both cultured cells and transgenic animals, as well as some human cell
data. It is a section which will be of use to the investigator as a review of successful
methodology in gene transfer. Most helpful is reference to the success ofthe expression
oftransgenes, which is, after all, a major purpose ofgene transfer as potential therapy
for genetic disorders. The section on human genetic diseases contains very little
information directly applicable to either gene transfer or gene therapy. Instead, it
focuses on advancing understanding of a number of inherited disorders whose major
relationship to each other is that they are inherited. The inclusion of these papers is
clearly justified by the fact that such molecular understanding is crucial to eventual
gene therapy.
Readers who expect that the book will live up to its title by providing finished
technology or even a single example of successful human gene therapy will be
disappointed. The information presented herewill, however, beofvalue toinvestigators